Citation Impact
Citing Papers
Deep Brain Stimulation for Treatment-Resistant Depression
2005 Standout
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
2012 Standout
Neural abnormalities during cognitive generation of affect in Treatment-Resistant depression
2003
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
2023 Standout
Predictors of nonresponse to cognitive behavioural therapy or venlafaxine using glucose metabolism in major depressive disorder
2009
Transcranial magnetic stimulation (TMS) of the human frontal cortex: implications for repetitive TMS treatment of depression
2004
Correlation of cerebral blood flow and treatment effects of repetitive transcranial magnetic stimulation in depressed patients
2002
Frontocingulate Dysfunction in Depression: Toward Biomarkers of Treatment Response
2010
Prefrontal cortical functional abnormality in major depressive disorder: A stereotactic meta-analysis
2006
Consensus paper of the WFSBP Task Force on Biological Markers: Biological Markers in Depression
2007
Depression
2018 Standout
From stress to inflammation and major depressive disorder: A social signal transduction theory of depression.
2014 Standout
Evidence of a Dissociation Pattern in Resting-State Default Mode Network Connectivity in First-Episode, Treatment-Naive Major Depression Patients
2011
Imaging phenotypes of major depressive disorder: genetic correlates
2009
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
2009 Standout
Cerebral metabolic correlates as potential predictors of response to anterior cingulotomy for treatment of major depression
2003
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
2016 Standout
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
2010 Standout
Exenatide once weekly plus dapagliflozin once daily versus exenatide or dapagliflozin alone in patients with type 2 diabetes inadequately controlled with metformin monotherapy (DURATION-8): a 28 week, multicentre, double-blind, phase 3, randomised controlled trial
2016
Microemulsion electrokinetic chromatography of drugs varying in charge and hydrophobicity Part II: Strategies for optimization of separation
2004
Resting anterior cingulate activity and abnormal responses to errors in subjects with elevated depressive symptoms: A 128‐channel EEG study
2005
Complementing Insulin Therapy to Achieve Glycemic Control
2013
Positron emission tomography imaging in depression: a neural systems perspective
2003
Disconnection of speech-relevant brain areas in persistent developmental stuttering
2002
Posterior cingulate cortex activation by emotional words: fMRI evidence from a valence decision task
2002
Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes: An interim analysis of data from the open-label, uncontrolled extension of three double-blind, placebo-controlled trials
2007
Microbial tryptophan catabolites in health and disease
2018 Standout
Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data
2006 Standout
Response surface methodology (RSM) as a tool for optimization in analytical chemistry
2008 Standout
Self-referential processing in our brain—A meta-analysis of imaging studies on the self
2006 Standout
Ego depletion and the strength model of self-control: A meta-analysis.
2010 Standout
Efficacy of Transcranial Magnetic Stimulation Targets for Depression Is Related to Intrinsic Functional Connectivity with the Subgenual Cingulate
2012 Standout
Pharmacological Treatment of the Overweight Patient
2007
Frontal Lobe Metabolic Decreases with Sleep Deprivation not Totally Reversed by Recovery Sleep
2006
The Subgenual Anterior Cingulate Cortex in Mood Disorders
2008
Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response
2000
When brain clocks lose track of time: cause or consequence of neuropsychiatric disorders
2011 StandoutNobel
Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment
2003
Bipolar and major depressive disorder: Neuroimaging the developmental-degenerative divide
2009
Neural basis of alertness and cognitive performance impairments during sleepiness. I. Effects of 24 h of sleep deprivation on waking human regional brain activity
2000
Differential limbic–cortical correlates of sadness and anxiety in healthy subjects: implications for affective disorders
2000
Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis
2012
Targeted electrode-based modulation of neural circuits for depression
2009
A meta-analysis of the impact of short-term sleep deprivation on cognitive variables.
2010 Standout
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
2010
A study of the reproducibility and etiology of diffusion anisotropy differences in developmental stuttering: A potential role for impaired myelination
2010
Incretin-Based Therapies: Review of Current Clinical Trial Data
2010
Functional Neuroanatomy of Emotion: A Meta-Analysis of Emotion Activation Studies in PET and fMRI
2002 Standout
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Sleep Deprivation Amplifies Reactivity of Brain Reward Networks, Biasing the Appraisal of Positive Emotional Experiences
2011
Incorporating Incretin-Based Therapies Into Clinical Practice: Differences Between Glucagon-Like Peptide 1 Receptor Agonists and Dipeptidyl Peptidase 4 Inhibitors
2010
The role of the posterior cingulate cortex in cognition and disease
2013 Standout
Limbic–frontal circuitry in major depression: a path modeling metanalysis
2004
A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study
2006
Biology of Incretins: GLP-1 and GIP
2007 Standout
An analysis of functional neuroimaging studies of dorsolateral prefrontal cortical activity in depression
2006
Efficacy of GLP-1 Receptor Agonists and DPP-4 Inhibitors: Meta-Analysis and Systematic Review
2012
The design and rationale of the Saxagliptin Assessment of Vascular Outcomes Recorded in patients with diabetes mellitus–Thrombolysis in Myocardial Infarction (SAVOR-TIMI) 53 Study
2011
Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
2013 Standout
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
2006 Standout
Interpersonal and social rhythm therapy: managing the chaos of bipolar disorder
2000
Type 2 diabetes
2017 Standout
Neuroimaging studies of mood disorders
2000
Power failure: why small sample size undermines the reliability of neuroscience
2013 Standout
Dynamic functional connectivity: Promise, issues, and interpretations
2013 Standout
White matter integrity, fiber count, and other fallacies: The do's and don'ts of diffusion MRI
2012 Standout
Dipeptidyl peptidase‐4 inhibitors in the treatment of type 2 diabetes: a comparative review
2010
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
2010
Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studies
2016
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2012 Standout
The Physiology of Glucagon-like Peptide 1
2007 Standout
The Metabolic Syndrome and Cardiovascular Disease: Part 2
2008
Investigating neural primacy in Major Depressive Disorder: multivariate Granger causality analysis of resting-state fMRI time-series data
2010
The cognitive control of emotion
2005 Standout
A Systematic Assessment of Cardiovascular Outcomes in the Saxagliptin Drug Development Program for Type 2 Diabetes
2010
The gut microbiota — masters of host development and physiology
2013 Standout
Sleep deprivation in depression
2010
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
2015 Standout
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
2017
Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic
2007 Standout
Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
2013 Standout
The cognitive neuroscience of sleep: neuronal systems, consciousness and learning
2002
Limbic Circuitry in Patients With Autism Spectrum Disorders Studied With Positron Emission Tomography and Magnetic Resonance Imaging
2000
Cortical Inefficiency in Patients with Unipolar Depression: An Event-Related fMRI Study with the Stroop Task
2006
Large-scale brain networks and psychopathology: a unifying triple network model
2011 Standout
The integration of negative affect, pain and cognitive control in the cingulate cortex
2011 Standout
The Intestinal Microbiota Affect Central Levels of Brain-Derived Neurotropic Factor and Behavior in Mice
2011 Standout
Comparison of different drugs as add-on treatments to metformin in type 2 diabetes: A meta-analysis
2007
The neurobiology of depression and antidepressant action
2012
Intestinal Microbiota During Infancy and Its Implications for Obesity
2009
The Incretin Mimetic Exenatide as a Monotherapy in Patients with Type 2 Diabetes
2007
Fluorine in medicinal chemistry
2007 Standout
Can Gut Hormones Control Appetite and Prevent Obesity?
2008
From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus
2009 Standout
Human performance under sustained operations and acute sleep deprivation conditions: toward a model of controlled attention.
2007
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy
2008 Standout
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
2014 Standout
Cardiovascular Biology of the Incretin System
2012
Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors
2017
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
A randomized controlled trial of the efficacy and safety of saxagliptin as add‐on therapy in patients with type 2 diabetes and inadequate glycaemic control on metformin plus a sulphonylurea
2013
Guidelines for the Primary Prevention of Stroke
2014 Standout
NRF2 activation by antioxidant antidiabetic agents accelerates tumor metastasis
2016
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Therapeutic use of sleep deprivation in depression
2002
Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years
2007
Venereal aspects of gastroenterology.
1979
The KEAP1-NRF2 System: a Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis
2018 Standout
Pneumocystis cariniiPneumonia and Mucosal Candidiasis in Previously Healthy Homosexual Men
1981 Standout
About Sleep's Role in Memory
2013 Standout
The Physiology of Willpower: Linking Blood Glucose to Self-Control
2007
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
β-Cell Failure in Diabetes and Preservation by Clinical Treatment
2007
The Metabolic Syndrome
2008 Standout
New Drugs for the Treatment of Diabetes
2008
Cardiovascular Actions of Incretin-Based Therapies
2014
Cardiovascular safety of sulfonylureas: a meta‐analysis of randomized clinical trials
2013
Works of E. Klein being referenced
A positron emission tomography [18F]deoxyglucose study of developmental stuttering
1995
Prediction of Antidepressant Effects of Sleep Deprivation by Metabolic Rates in the Ventral Anterior Cingulate and Medial Prefrontal Cortex
1999
Metformin‐glibenclamide versus metformin plus rosiglitazone in patients with type 2 diabetes inadequately controlled on metformin monotherapy
2005
Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82 weeks in 314 overweight patients with type 2 diabetes
2006
Efficacy and Tolerability of Exenatide Once Weekly Over 6 Years in Patients with Type 2 Diabetes: An Uncontrolled Open-Label Extension of the DURATION-1 Study
2016
Anorectal Gonococcal Infection
1977
A REVIEW OF CRITERIA FUNCTIONS AND RESPONSE SURFACE METHODOLOGY FOR THE OPTIMIZATION OF ANALYTICAL SCALE HPLC SEPARATIONS
2000
Effect of saxagliptin monotherapy in treatment-naïve patients with type 2 diabetes
2009